Abstract |
The low in vivo transduction efficiency of recombinant adeno-associated virus (rAAV) and the undesirably strong immunogenicity of adenovirus (rAdv) have limited their clinical utilization in cancer gene therapy. We have previously demonstrated that intratumoral injection of rAAV expressing a C-terminal polypeptide of human telomerase reverse transcriptase (rAAV-hTERTC27) effectively inhibits the growth of glioblastoma xenografts in nude mice. To further improve its efficacy, we combined rAAV-hTERTC27 with rAdv and investigated the efficiency of the cocktail vectors in vivo. At a nontherapeutic dose (1 x 10(8) plaque-forming units (PFUs)), rAdv-null and rAdv-hTERTC27 were equipotent in enhancing the therapeutic efficacy of rAAV-hTERTC27 (1.5 x 10(11) v.g.), and complete tumor regression was achieved in 25% of the treated animals. Importantly, the combination of rAAV-hTERTC27 and a therapeutic dose (2.5 x 10(9) PFU) of rAdv-hTERTC27 significantly augmented the therapeutic effects and led to a 38% complete tumor regression rate. In vivo optical imaging also showed that rAAV-luc/rAdv-luc cocktail vectors could synergistically enhance the early transient and latent sustained expression of luciferase, as compared to rAdv-luc and rAAV-luc alone. These findings suggest that the combination of rAAV-hTERTC27 and a therapeutic dose of rAdv-hTERTC27 is potentially a promising treatment for glioblastoma, and the rAAV/rAdv cocktail vector system warrants further development for cancer gene therapy.
|
Authors | Y Gao, S S M Ng, D H W Chau, H Yao, C Yang, K Man, P T Huang, C Huang, J J Huang, H-F Kung, M C Lin |
Journal | Cancer gene therapy
(Cancer Gene Ther)
Vol. 15
Issue 11
Pg. 723-32
(Nov 2008)
ISSN: 1476-5500 [Electronic] England |
PMID | 18535618
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- DNA Primers
- Luciferases
- TERT protein, human
- Telomerase
|
Topics |
- Adenoviridae
(genetics)
- Animals
- DNA Primers
(genetics)
- Dependovirus
(genetics)
- Gene Transfer Techniques
- Genetic Therapy
(methods)
- Genetic Vectors
(genetics)
- Glioblastoma
(genetics, therapy)
- Humans
- Luciferases
- Mice
- Mice, Nude
- Reverse Transcriptase Polymerase Chain Reaction
- Telomerase
(genetics)
- Transduction, Genetic
(methods)
|